This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Despite untold investment by numerous pharmaceuticalcompanies, FDA-approved drugs that target critical brain functions and conditions like anxiety, depression, and sedation continue to present severe and unpredictable side effects, including suicidal ideation. In 2003 the Human Genome Project provided the first atlas.
Medscape’s Adrian Duncan explores findings from an FDA trial looking at the impact of digital medical education on antibiotic prescribing. Emma Sutcliffe explains how to build partnerships that are not defined by the volume of the interactions but instead by the value that each interaction brings to all stakeholders.
Pharmaceuticalcompanies have long taken notice of this opportunity, developing a wave of therapies that are now entering the market. FDA data indicates that while the number of orphan designations has been increasing over the last half-decade, the number of unique indications has been decreasing 3.
Award & Nominations: For her contributions to the pharmaceutical sector and business, Emma received the rank of Dame Commander (DBE) in the 2020 Queen's Birthday Honours. With more than $50 billion in annual global revenue, Janssen has grown to be the second-largest innovative pharmaceuticalcompany under her direction.
Surrounded by universities and community colleges with life sciences programs, companies in RTP were able to access highly skilled graduates, increasing employment in the state. By the 1990s, pharmaceuticalcompanies were looking to partner with contract research organizations (CROs) for drug development and clinical trials.
In an era when the world is accelerating the development of drugs and targeted medicines using innovative technologies, pharmaceuticalcompanies still face registration hurdles for well-characterized molecules because of redundant or additional local regulatory requirements. Modernization of the FDA CDER Export Certificate Program.”
Yeah, I even wanted to wear the shirt to this FDA meeting. You know, in November 2009, the FDA held a public hearing about the promotion of Food and Drug Administrative Related Regulated Medical Products, using the internet and social media tools. It wasn’t just pharmaceuticalcompanies and others.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content